Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
411.00    -13.00 (-3.07%)
Bid:
411.00
Ask:
415.50
Spread: 4.50 (1.095%)
Market Cap: £202.14m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

15 Dec 2022 07:00

RNS Number : 7596J
Zotefoams PLC
15 December 2022
 

Zotefoams plc

("Zotefoams" or "Group" or "Company")

 

Trading Update

Continued positive momentum through Q4 and full year profit ahead of market expectations

 

15 December 2022 - Zotefoams, a world leader in cellular materials technology, today provides an update in respect of its financial year ending 31 December 2022.

As communicated in the Group's trading update of 13 October, performance over the nine months to 30 September 2022 had been strong, with revenues approximately 24% ahead of the comparable prior year period. 

Encouragingly, trading during October and November has remained strong, with both the Polyolefin Foams and High-Performance Products businesses continuing to deliver year-on-year growth as well as a continued focus on cost and efficiency. As a result, based on current FX rates, the Board now expects Group FY22 adjusted profit before income tax to be ahead of current market expectations*, with the extent of the outperformance primarily dependent on the timing of customer shipments in the final weeks of the year.

Cash generation also continues to be positive. The better than anticipated earnings performance should contribute to an appreciable reduction in leverage compared with that reported in the interims at 30 June 2022. 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"I am pleased that Zotefoams continues to perform well and deliver excellent growth in both revenue and profitability. Whilst this year has seen considerable challenges in the form of both cost and demand volatility, we have continued to demonstrate resilience in mitigating these, which is testament to Zotefoams' well-established products and experienced team.

"Whilst we expect a number of the challenges experienced this year to continue into 2023, we are confident in our ability to respond and we continue to see significant opportunity for the Group."

 

* Current Company-compiled consensus expectations for adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2022, is £10.7m.

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZMMZRDKGZZM
Date   Source Headline
25th Mar 20211:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:19 pmRNSCorrection: Preliminary Results
23rd Mar 20217:00 amRNSPreliminary Results
12th Mar 20212:53 pmRNSDirector/PDMR Shareholding
10th Mar 20211:12 pmRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
9th Mar 20213:05 pmRNSHolding(s) in Company
9th Mar 20211:55 pmRNSHolding(s) in Company
8th Mar 20213:04 pmRNSResult of secondary placing in Zotefoams plc
8th Mar 202112:00 pmRNSProposed secondary placing in Zotefoams plc
8th Mar 20217:00 amRNSNotice of results and investors presentation
5th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20217:00 amRNSProduction starts at new £23m plant in Poland
15th Feb 20217:00 amRNSPolish factory virtual tour and investor Q&A
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding - Replacement
12th Feb 20213:54 pmRNSDirector/PDMR Shareholding
12th Feb 20213:38 pmRNSDirector/PDMR Shareholding
8th Feb 20214:41 pmRNSSecond Price Monitoring Extn
8th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSOperational and Trading Update
12th Jan 20213:50 pmRNSDirector/PDMR Shareholding
14th Dec 20204:19 pmRNSDirector/PDMR Shareholding
12th Nov 20203:40 pmRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSOperational and Trading Update
22nd Oct 202010:36 amRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSExternal Auditor Appointment
1st Oct 20204:13 pmRNSDirector/PDMR Shareholding
16th Sep 20204:29 pmRNSDirector/PDMR Shareholding
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
9th Sep 20205:51 pmRNSHolding(s) in Company
1st Sep 20204:40 pmRNSSecond Price Monitoring Extn
1st Sep 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202010:54 amRNSDirector/PDMR Shareholding
12th Aug 20203:52 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSInterim Results
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Results
16th Jun 20205:05 pmRNSHolding(s) in Company
12th Jun 20203:25 pmRNSDirector/PDMR Shareholding
8th Jun 20202:06 pmRNSResult of the 2020 Annual General Meeting
2nd Jun 20208:00 amRNSOperational and Trading Update
22nd May 202012:07 pmRNSSecond Price Monitoring Extn
22nd May 202012:02 pmRNSPrice Monitoring Extension
14th May 20203:48 pmRNSIssue of Equity
14th May 20203:15 pmRNSDirector/PDMR Shareholding
6th May 20207:00 amRNS2019 Annual Report and Notice of the 2020 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.